Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Richard S. Burns, Chuang C. Chiueh, Sanford P. Markey et al. · Proceedings of the National Academy of Sciences · 1983 · 2.1K citations · Full text

Medicine, Neuroscience, Pharmacology +17

Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus

Hagai Bergman, Thomas Wichmann, Mahlon R. DeLong · Science · 1990 · 1.9K citations

Life Sciences, Neurology, Neuroscience +17

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

Glenn C. Davis, Adrian Williams, Sanford P. Markey et al. · Psychiatry Research · 1979 · 1.4K citations

Medicine, Neurology, Pharmacology +16

Core assessment program for intracerebral transplantations (CAPIT)

J. William Langston, Håkan Widner, Christopher G. Goetz et al. · Movement Disorders · 1992 · 1K citations

Medicine, Neurological Surgery, Surgery +12

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

J. William Langston, Lysia S. Forno, Charles S. Rebert et al. · Brain Research · 1984 · 919 citations

Medicine, Pharmacology, Toxicology +5